Fangzhou Inc., a leading Internet healthcare solutions provider, was recently honored for its contributions to advancing AI technology in online healthcare and chronic disease management. The company was featured on the 2024 Guangdong “AI Catalyst” Enterprise Billboard at the Guangdong-Hong Kong-Macao Greater Bay Area Artificial Intelligence Industry Conference. Fangzhou’s platform utilizes AI assistants and big data to improve chronic disease management services for both patients and healthcare providers.
CEO Xie Fangmin expressed gratitude for the recognition, emphasizing the company’s dedication to improving healthcare through technological innovation. Guangdong, at the forefront of AI integration, has been actively promoting AI applications across various industries. Measures have been introduced to create AI-driven scenarios in manufacturing, education, and senior care, as well as initiatives to position Guangdong as a leading biotech hub.
Fangzhou Inc. is China’s leading online chronic disease management platform, boasting millions of registered users and doctors on its platform. The company focuses on providing personalized medical care and precision medicine for chronic disease patients. The 2024 Guangdong-Hong Kong-Macao Greater Bay Area Artificial Intelligence Industry Conference, organized by the Guangdong Association of Artificial Intelligence Industry, brought together key industry leaders and academicians to discuss AI trends and technological advancements. For more information, visit their website.
Source
Photo credit www.prnewswire.com
Fangzhou Inc. Recognized as a Leading Innovator in the AI Technology Industry
